Tag: Eylea

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Eylea

Regeneron Reports Fourth Quarter and Full Year 2019 Financial and Operating Results

Added to Collection on: 2020-02-05 19:26:15

Tags for this article:

Companies
Sanofi
Industry economics)
Health care
Regeneron Pharmaceuticals
Fundamental analysis
Tax expense
Aflibercept
Alirocumab
Net operating loss
BAS
Earnings per share
Dupilumab
REGENERON GENETICS CENTER
Eylea
United States

Click the tags to see associated articles and topics

View Article Details
With biosimilars looming, Roche makes case for new biologic eye drug

Added to Collection on: 2020-12-21 17:26:15

Tags for this article:

Ophthalmology
Drugs
Clinical medicine
Angiogenesis inhibitors
Breakthrough therapy
Orphan drugs
Macular edema
Aflibercept
Ranibizumab
Bevacizumab
Diabetic retinopathy
Regeneron Pharmaceuticals
Lucentis
Eylea
Roche

Click the tags to see associated articles and topics

View Article Details
Roche eyes an uncertain market for faricimab

Added to Collection on: 2020-12-22 15:11:15

Tags for this article:

Health sciences
Health care
Drugs
Breakthrough therapy
Angiogenesis inhibitors
Aflibercept
Sanofi
Orphan drugs
Monoclonal antibodies
Macular edema
Ranibizumab
Regeneron Pharmaceuticals
Regeneron
Eylea

Click the tags to see associated articles and topics

View Article Details
Regeneron shoots for longer Eylea dosing interval in diabetic retinopathy with NIH data

Added to Collection on: 2021-04-02 12:00:00

Tags for this article:

Ophthalmology
Organ systems
Clinical medicine
Breakthrough therapy
Angiogenesis inhibitors
Aflibercept
Sanofi
Orphan drugs
Macular edema
Ranibizumab
Diabetic retinopathy
Regeneron Pharmaceuticals
Regeneron
Eylea

Click the tags to see associated articles and topics

View Article Details
Regeneron's Eylea beats out the competition in the US as patient demand picks back up

Added to Collection on: 2021-05-06 15:31:09

Tags for this article:

Companies
Life Sciences
Health care
Breakthrough therapy
Regeneron Pharmaceuticals
Angiogenesis inhibitors
Monoclonal antibodies
Sanofi
Aflibercept
Novartis
Ranibizumab
George Yancopoulos
Regeneron
United States
Eylea

Click the tags to see associated articles and topics

View Article Details
Regeneron (REGN) Down as Q4 Eylea Preliminary Sales Disappoint - Yahoo Finance

Added to Collection on: 2024-01-09 18:10:36

Tags for this article:

Sanofi
Regeneron Pharmaceuticals
Aflibercept
Macular edema
Bayer
Dupilumab
Pharmaceutical industry
Eylea

Click the tags to see associated articles and topics

View Article Details
FDA grants approval for Eylea®1) biosimilar FYB203/AHZANTIVE®2) (aflibercept-mrbb)

Added to Collection on: 2024-06-29 10:00:22

Tags for this article:

Angiogenesis inhibitors
Aflibercept
Sanofi
Blindness
Macular edema
Diabetic retinopathy
Macular degeneration
Central retinal vein occlusion
Forward-looking statement
Regeneron Pharmaceuticals
Biosimilar
Macula
Formycon AG
Eylea

Click the tags to see associated articles and topics

View Article Details
REGN Loses 21.1% Year to Date: Buy, Sell or Hold the Sock? - TradingView

Added to Collection on: 2025-09-15 15:32:00

Tags for this article:

Sanofi
Regeneron Pharmaceuticals
Aflibercept
Macular edema
Bayer
Dupilumab
Cemiplimab
Central retinal vein occlusion
Priority review
Eylea
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
Book a Demo